Bluejay Diagnostics, Inc. Proceeds from Issuance of Private Placement
Bluejay Diagnostics, Inc. (BJDX) had Proceeds from Issuance of Private Placement of $4.50 million as of 2025-10-10, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-12
- 2025-10-10: Proceeds from Issuance of Private Placement $4.50M.
- 2025-10-09: Proceeds from Issuance of Private Placement $4.50M.
| Period end | Proceeds from Issuance of Private Placement |
|---|---|
| 2025-10-10 | $4.50M 10-Q · filed 2026-08-12 |
| 2025-10-09 | $4.50M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |